148 related articles for article (PubMed ID: 1689578)
41. Photofootprinting of drug-binding sites on DNA using diazo- and azido-9-aminoacridine derivatives.
Jeppesen C; Nielsen PE
Eur J Biochem; 1989 Jun; 182(2):437-44. PubMed ID: 2472274
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of transcription factor-DNA complexes and gene expression by a microgonotropen.
White CM; Satz AL; Bruice TC; Beerman TA
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10590-5. PubMed ID: 11535831
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.
Walker J; Saravia NG
J Parasitol; 2004 Oct; 90(5):1155-62. PubMed ID: 15562618
[TBL] [Abstract][Full Text] [Related]
44. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
Jaxel C; Kohn KW; Pommier Y
Nucleic Acids Res; 1988 Dec; 16(23):11157-70. PubMed ID: 2849758
[TBL] [Abstract][Full Text] [Related]
45. Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.
Poddevin B; Riou JF; Lavelle F; Pommier Y
Mol Pharmacol; 1993 Oct; 44(4):767-74. PubMed ID: 8232227
[TBL] [Abstract][Full Text] [Related]
46. A new mammalian DNA topoisomerase I poison Hoechst 33342: cytotoxicity and drug resistance in human cell cultures.
Chen AY; Yu C; Bodley A; Peng LF; Liu LF
Cancer Res; 1993 Mar; 53(6):1332-7. PubMed ID: 8383008
[TBL] [Abstract][Full Text] [Related]
47. The role of base excision repair in the repair of DNA adducts formed by a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size.
Brooks N; McHugh PJ; Lee M; Hartley JA
Anticancer Drug Des; 1999 Feb; 14(1):11-8. PubMed ID: 10363024
[TBL] [Abstract][Full Text] [Related]
48. Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei.
Pommier Y; Schwartz RE; Zwelling LA; Kohn KW
Biochemistry; 1985 Nov; 24(23):6406-10. PubMed ID: 3002439
[TBL] [Abstract][Full Text] [Related]
49. Induction of DNA-protein crosslinks by antitumor 1-nitro-9-aminoacridines in L1210 leukemia cells.
Woynarowski JM; McNamee H; Szmigiero L; Beerman TA; Konopa J
Biochem Pharmacol; 1989 Nov; 38(22):4095-101. PubMed ID: 2557039
[TBL] [Abstract][Full Text] [Related]
50. Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer.
Filipowsky ME; Kopka ML; Brazil-Zison M; Lown JW; Dickerson RE
Biochemistry; 1996 Dec; 35(48):15397-410. PubMed ID: 8952492
[TBL] [Abstract][Full Text] [Related]
51. UCN-01 and camptothecin induce DNA double-strand breaks in p53 mutant tumor cells, but not in normal or p53 negative epithelial cells.
Jones CB; Clements MK; Redkar A; Daoud SS
Int J Oncol; 2000 Nov; 17(5):1043-51. PubMed ID: 11029511
[TBL] [Abstract][Full Text] [Related]
52. Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
Beria I; Baraldi PG; Cozzi P; Caldarelli M; Geroni C; Marchini S; Mongelli N; Romagnoli R
J Med Chem; 2004 May; 47(10):2611-23. PubMed ID: 15115402
[TBL] [Abstract][Full Text] [Related]
53. Hoechst 33342 induces apoptosis in HL-60 cells and inhibits topoisomerase I in vivo.
Zhang X; Chen J; Davis B; Kiechle F
Arch Pathol Lab Med; 1999 Oct; 123(10):921-7. PubMed ID: 10506445
[TBL] [Abstract][Full Text] [Related]
54. Specific interaction of camptothecin, a topoisomerase I inhibitor, with guanine residues of DNA detected by photoactivation at 365 nm.
Leteurtre F; Fesen M; Kohlhagen G; Kohn KW; Pommier Y
Biochemistry; 1993 Aug; 32(34):8955-62. PubMed ID: 8395887
[TBL] [Abstract][Full Text] [Related]
55. Low-level resistance to camptothecin in a human small-cell lung cancer cell line without reduction in DNA topoisomerase I or drug-induced cleavable complex formation.
Sorensen M; Sehested M; Christensen IJ; Larsen JK; Jensen PB
Br J Cancer; 1998 Jun; 77(12):2152-61. PubMed ID: 9649127
[TBL] [Abstract][Full Text] [Related]
56. Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.
Pierson V; Pierre A; Pommier Y; Gros P
Cancer Res; 1988 Mar; 48(6):1404-9. PubMed ID: 2830964
[TBL] [Abstract][Full Text] [Related]
57. In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.
Pondarré C; Strumberg D; Fujimori A; Torres-León R; Pommier Y
Nucleic Acids Res; 1997 Oct; 25(20):4111-6. PubMed ID: 9321666
[TBL] [Abstract][Full Text] [Related]
58. A-T specific DNA ligands and hypotonic induced supercondensation of chromocentre in brain cells of Drosophila nasuta larvae in relation to their synthetic activities.
Roy JK; Lakhotia SC
Indian J Exp Biol; 1984 Jun; 22(6):287-91. PubMed ID: 6210246
[No Abstract] [Full Text] [Related]
59. The mutagenic properties of DNA minor-groove binding ligands.
Turner PR; Denny WA
Mutat Res; 1996 Aug; 355(1-2):141-69. PubMed ID: 8781582
[TBL] [Abstract][Full Text] [Related]
60. DNA damage and cytotoxicity in L1210 cells by ellipticine and a structural analogue, N-2-(diethylaminoethyl)-9-hydroxyellipticinium chloride.
Djuric Z; Everett CK; Valeriote FA
Cancer Res; 1992 Mar; 52(6):1515-9. PubMed ID: 1540960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
